These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6095584)

  • 21. Beta-adrenoceptor changes in mononuclear leukocytes during pregnancy.
    Nwosu UC; Rice PJ
    Proc Soc Exp Biol Med; 1995 Jun; 209(2):157-62. PubMed ID: 7770466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide.
    Zetterlund A; Hjemdahl P; Larsson K
    Clin Sci (Lond); 2001 Apr; 100(4):451-7. PubMed ID: 11256987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypokalemia associated with terbutaline administration in obstetrical patients.
    Moravec MA; Hurlbert BJ
    Anesth Analg; 1980 Dec; 59(12):917-20. PubMed ID: 6108735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial serum potassium and glucose levels during treatment of premature labor with oral terbutaline.
    Jovanovic R
    Int J Gynaecol Obstet; 1985 Oct; 23(5):399-404. PubMed ID: 2866991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of ritodrine to prevent preterm labor in the sheep.
    Lye SJ; Dayes BA; Freitag CL; Brooks J; Casper RF
    Am J Obstet Gynecol; 1992 Nov; 167(5):1399-408. PubMed ID: 1332478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of terbutaline on premature labor. A double-blind placebo-controlled study.
    Ingemarsson I
    Am J Obstet Gynecol; 1976 Jun; 125(4):520-4. PubMed ID: 790961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study of phosphodiesterase-inhibiting drugs: a complement to beta-sympathomimetic drug therapy in premature labor?
    Berg G; Andersson RG; Rydén G
    Am J Obstet Gynecol; 1983 Apr; 145(7):802-6. PubMed ID: 6301281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Success rate of terbutaline in inhibiting preterm labor for 48 h.
    Theplib A; Phupong V
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):841-4. PubMed ID: 25758629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terbutaline by pump to prevent recurrent preterm labor.
    Gill P; Smith M; McGregor C
    MCN Am J Matern Child Nurs; 1989; 14(3):163-7. PubMed ID: 2498593
    [No Abstract]   [Full Text] [Related]  

  • 31. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
    Wenstrom KD; Weiner CP; Merrill D; Niebyl J
    Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of interleukin-6 by beta2-adrenoceptor in endotoxin-stimulated renal macrophage cells.
    Nakamura A; Johns EJ; Imaizumi A; Yanagawa Y; Kohsaka T
    Kidney Int; 1999 Sep; 56(3):839-49. PubMed ID: 10469353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor redistribution does not accompany terbutaline-induced down regulation of beta-adrenergic receptors on human mononuclear leukocytes.
    Maisel AS; Motulsky HJ
    Clin Pharmacol Ther; 1987 Jul; 42(1):100-6. PubMed ID: 3036413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.
    Lam F; Istwan NB; Jacques D; Coleman SK; Stanziano GJ
    Manag Care; 2003 Jul; 12(7):39-46. PubMed ID: 12891954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
    Chong LK; Suvarna K; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of oral terbutaline after intravenous tocolysis.
    Parilla BV; Dooley SL; Minogue JP; Socol ML
    Am J Obstet Gynecol; 1993 Oct; 169(4):965-9. PubMed ID: 8238158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease.
    Lipworth BJ; Clark RA; Dhillon DP; McDevitt DG
    Am Rev Respir Dis; 1990 Aug; 142(2):338-42. PubMed ID: 2166455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of resensitization of rat uterine beta-adrenoceptor system.
    Andersson RG; Johansson SR; Salomonsson I
    Pharmacol Toxicol; 1988 Jan; 62(1):29-31. PubMed ID: 2833738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum estriol levels during beta-receptor agonist infusion in the third trimester of pregnancy.
    Bremme K; Eneroth P
    Gynecol Obstet Invest; 1981; 12(2):93-8. PubMed ID: 6114905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.